| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2014-09-17 | MGB Biopharma (UK) | £4.0 million ($6.4 million - €5.02 million) | financing round | Archangels (UK), Barwell PLC (UK), TRI Cap (UK), the Scottish Investment Bank (UK) | Infectious diseases | Financing round |
| 2014-09-17 | Affimed (Germany) | $ 56 million | IPO | Cancer - Oncology | IPO | |
| 2014-09-16 | Inventiva (France) Curie-Cancer (France) | grant | ANR - French National Research Agency (France) | Cancer - Oncology - Respiratory diseases | Grant | |
| 2014-09-16 | Nordic Nanovector (Norway) | NOK 50 million ($7,8 million - €6 million) | private placement | HealthCap, existing shareholders, new institutional and professional investors | Cancer - Oncology | Private placement |
| 2014-09-15 | Morphosys (Germany) | up to € 1 million | grant | German Ministry of Education and Research (BMBF) (Germany) | Grant | |
| 2014-09-12 | Osmia Pharmaceutical (Sweden) | IPO | Veterinary medicine - Cancer - Oncology | IPO | ||
| 2014-09-11 | Mimetas (The Netherlands) | $1.6 million | grant | Grant | ||
| 2014-09-10 | Beta-O2 (Israel) | $0.5 million | grant | JDRF (USA - NY) | Metabolic diseases - Regenerative medicine | Grant |
| 2014-09-10 | Alize Pharma (France) | € 5 million | financing round | Bpifrance (France), Octalfa (France), Sham Innovation Sante (France), CEMA (Canada), TAB Consulting (France) | Metabolic diseases - Rare diseases | Financing round |
| 2014-09-10 | AM-Pharma (The Netherlands) | €12.2 million | financing round | Gilde Healthcare (The Netherlands) - Ysios Capital Partners (Spain) - Kurma Biofund (France) - Abbvie (USA) - BB Biotech Ventures (Switzerland) - Idinvest Partners (France) - Inventages Venture Capital (UK-Switzerland-New Zealand-Bahamas) | Inflammatory diseases | Financing round |
| 2014-09-09 | Poxel (France) | €10 million | series B financing round | Edmond de Rothschild Investment Partners - EdRIP (France) InnoBio (France) Omnes Capital - formerly Crédit Agricole Private Equity (France) | Metabolic diseases | Series B financing round |
| 2014-09-09 | Therametrics, formerly known as Mondobiotech (Switzerland) | CHF 20 million (€16.5 million) | private placement | Fin Posillipo (Italy), existing and new shareholders | Technology - Services | Capital increase |
| 2014-09-09 | F2G (UK) | £1.4 million | grant | Biomedical Catalyst Fund (UK) | Infectious diseases | Grant |
| 2014-09-07 | Cardiorentis (Switzerland) | € 45 million | fundraising | HealthCare Royalty Partners (USA) | Cardiovascular diseases | Fundraising |
| 2014-09-04 | Biocartis (Belgium) | € 64.5 million | financing round | Johnson & Johnson Development Corporation, a J&J company (USA - NJ) , Hitachi Chemical Corporation (Japan), PMV Tina Fund (Belgium), undisclosed family offices | Diagnostic - Cancer - Oncology - Infectious diseases | Financing round |
| 2014-09-04 | MyCartis (Belgium) | € 15 million | financing round | RMM, Valiance (UK), Biover II (Belgium) | Diagnostic | Financing round |
| 2014-09-04 | Biomay (Austria) | €2.8 million | capital increase | existing shareholders | Allergic diseases | Capital increase |
| 2014-09-03 | 4SC AG (Germany) | €500,000.00 | fundraising | Yorkville Advisors LLC (USA) | Fundraising | |
| 2014-09-02 | Quantum Genomics (France) | 260 K€ | fundraising | Bpifrance (France) | Cardiovascular diseases | Fundraising |
| 2014-09-02 | Affimed (Germany) | $29.7 million (€22.2 million) | series E financing round, loan | Cancer - Oncology | Financing round |
